Insider · CIK 0001783697
GRIFFITH MELINDA
Reports to the SEC for 1 company · ALAMEDA, CA
Transactions
8
Companies
1
Filings
4
CIK
0001783697
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2022-08-16 | IMDXInsight Molecular Diagnostics Inc.P Purchase | +$10K |
| 2022-08-15 | IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockA Award | — |
| 2022-08-15 | IMDXInsight Molecular Diagnostics Inc.A Award | — |
| 2022-06-24 | IMDXInsight Molecular Diagnostics Inc.M Exercise/Conversion | — |
| 2022-06-24 | IMDXInsight Molecular Diagnostics Inc. · Restricted Stock UnitsM Exercise/Conversion | — |
| 2021-06-24 | IMDXInsight Molecular Diagnostics Inc. · Option to Purchase Common StockA Award | — |
| 2021-06-24 | IMDXInsight Molecular Diagnostics Inc. · Restricted Stock UnitsA Award | — |
| 2020-06-17 | IMDXInsight Molecular Diagnostics Inc. · Option to purchase common stockA Award | — |
Recent filings
- 4GRIFFITH MELINDA0001493152-22-023378SEC(opens sec.gov)
- 4GRIFFITH MELINDA0001493152-22-019819SEC(opens sec.gov)
- 4GRIFFITH MELINDA0001493152-21-015447SEC(opens sec.gov)
- 4GRIFFITH MELINDA0001493152-20-011543SEC(opens sec.gov)
Companies
Address
C/O ONCOCYTE CORPORATION 1010 ATLANTIC AVENUE, SUITE 102
ALAMEDA, CA, 94501